The green tea polyphenol EGCG inhibits E. coli biofilm formation by impairing amyloid curli fibre assembly and downregulating the biofilm regulator CsgD via the σE-dependent sRNA RybB

Molecular Microbiology

Volumn 101, Issue 1, 2016, Pages 136-151

  Serra, Diego O ^a   Mika, Franziska ^a   Richter, Anja M ^a   Hengge, Regine ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BACTERIAL PROTEIN; EPIGALLOCATECHIN GALLATE; PROTEIN CSGD; PROTEIN RYBB; TRANSFER RNA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIUM COLONY; BIOFILM; CONTROLLED STUDY; DOWN REGULATION; DRUG STRUCTURE; ENZYME INHIBITION; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; TEA;

EID: 84976574961     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/mmi.13379     Document Type: Article

References (54)

1. Ades, S.E. (2008) Regulation by destruction: design of the sigmaE envelope stress response. Curr Opin Microbiol 11: 535–540.
2. Balentine, D.A., and Paetau-Robinson, I. (2000) Tea as a source of dietary antioxidants with a potential role on prevention of chronic diseases. In Herbs, Botanicals & Teas. Mazza, G., and Oomah, B.D. (eds.). Lancaster: Technomic Publishing Co. Inc., pp. 265–287.
3. Bieschke, J., Russ, J., Friedrich, R.P., Ehrnhoefer, D.E., Wobst, H., Neugebauer, K., and Wanker, E.E. (2010) EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc Natl Acad Sci USA 107: 7710–7715.
4. Bikels-Goshen, T., Landau, E. Saguy, S., and Shapira, R. (2010) Staphylococcal strains adapted to epigallocathechin gallate (EGCG) show reduced susceptibility to vancomycin, oxacillin and ampicillin, increased heat tolerance, and altered cell morphology. Int J Food Microbiol 138: 26–31.
5. Bjarnsholt, T., O. Ciofu, S. Molin, M. Givskov and N. Hoiby, (2013) Applying insights from biofilm biology to drug development - can a new approach be developed? Nature reviews. Drug discovery 12: 791–808.
6. Blanco, A.R., Sudano-Roccaro, A., Spoto, G.C., Nostro, A., and Rusciano, D. (2005) Epigallocatechin gallate inhibits biofilm formation by ocular staphylococcal isolates. Antimicrob Agents Chemother 49: 4339–4343.
7. Cegelski, L., Pinkner, J.S., Hammer, N.D., Cusumano, C.K., Hung, C.S., Chorell, E., et al. (2009) Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol 5: 913–919.
8. Cui, Y., Kim, S.H., Kim, H., Yeom, J., Ko, K., Park, W., and Park, S. (2012) AFM probing the mechanism of synergistic effects of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) with cefotaxime against extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. PloS One 7: e48880.
9. de la Fuente-Nunez, C., Reffuveille, F., Haney, E.F., Straus, S.K., and Hancock, R.E. (2014) Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog 10: e1004152.
10. Ehrnhoefer, D.E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., et al. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15: 558–566.
11. Evans, M.L., and Chapman, M.R. (2014) Curli biogenesis: order out of disorder. Biochim Biophys Acta, 1843: 1551–1558
12. Flemming, H.C., and Wingender, J. (2010) The biofilm matrix. Nat Rev Microbiol 8: 623–633.
13. Gogol, E.B., Rhodius, V.A., Papenfort, K., Vogel, J., and Gross, C.A. (2011) Small RNAs endow a transcriptional activator with essential repressor functions for single-tier control of a global stress regulon. Proc Natl Acad Sci USA 108: 12875–12880.
14. Hall-Stoodley, L., Costerton, J.W., and Stoodley, P. (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2: 95–108.
15. Hengge, R. (2009) Principles of c-di-GMP signalling in bacteria. Nature Rev Microbiol 7: 263–273.
16. Hengge, R. (2011) The general stress response in gram-negative bacteria. In Bacterial stress responses. Storz, G. and Hengge, R. (eds.). Washington, DC: ASM press, pp. 251–289.
17. Ikigai, H., Nakae, T., Hara, Y., and Shimamura, T. (1993) Bactericidal catechins damage the lipid bilayer. Biochim Biophys Acta 1147: 132–136.
18. Isogai, E., Isogai, H., Hirose, K. Hayashi, S., and Oguma, K. (2001) In vivo synergy between green tea extract and levofloxacin against enterohemorrhagic Escherichia coli O157 infection. Curr Microbiol 42: 248–251.
19. Johannes, L., and Romer, W. (2010) Shiga toxins – from cell biology to biomedical applications. Nat Rev Microb 8: 105–116.
20. Johansen, J., Rasmussen, A.A., Overgaard, M., and Valentin-Hansen, P. (2006) Conserved small non-coding RNAs that belong to the sigmaE regulon: role in down-regulation of outer membrane proteins. J Mol Biol 364: 1–8.
21. Jubelin, G., Vianney, A., Beloin, C., Ghigo, J.M., Lazzaroni, J.C., Lejeune, P., and Dorel, C. (2005) CpxR/OmpR interplay regulates curli gene expression in response to osmolarity in Escherichia coli. J Bacteriol 187: 2038–2049.
22. Kostakioti, M., Hadjifrangiskou, M., and Hultgren, S.J. (2013) Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med 3: a010306.
23. Larsen, P., Nielsen, J.L., Dueholm, M.S., Wetzel, R., Otzen, D., and Nielsen, P.H. (2007) Amyloid adhesins are abundant in natural biofilms. Env Microbiol 9: 3077–3090.
24. Lee, K.M., Kim, W.S., Lim, J., Nam, S., Youn, M., Nam, S.W., et al. (2009) Antipathogenic properties of green tea polyphenol epigallocatechin gallate at concentrations below the MIC against enterohemorrhagic Escherichia coli O157:H7. J Food Protection 72: 325–331.
25. Lewis, K. (2008) Multidrug tolerance of biofilms and persister cells. Current topics in microbiology and immunology 322: 107–131.
26. Lindenberg, S., Klauck, G., Pesavento, C., Klauck, E., and Hengge, R. (2013) The EAL domain protein YciR acts as a trigger enzyme in a c-di-GMP signalling cascade in E. coli biofilm control. EMBO J 32: 2001–2014.
27. Maisonneuve, E., and Gerdes, K. (2014) Molecular mechanisms underlying bacterial persisters. Cell 157: 539–548.
28. Mascher, T. (2013) Signaling diversity and evolution of extracytoplasmic function (ECF) sigma factors. Curr Opin Microbiol 16: 148–155.
29. Mika, F., and Hengge, R. (2014) Small RNAs in the control of RpoS, CsgD, and biofilm architecture of Escherichia coli. RNA Biol 11: 494–507.
30. Mika, F., Busse, S., Possling, A., Berkholz, J., Tschowri, N., Sommerfeldt, N., et al. (2012) Targeting of csgD by the small regulatory RNA RprA links stationary phase, biofilm formation and cell envelope stress in Escherichia coli. Mol Microbiol 84: 51–65.
31. Miyamoto, T., Toyofuku, S., Tachiki, N., Kimura, E., Zhou, T. Ozawa, T., et al. (2014) Specific inhibition of cytotoxicity of Shiga-like toxin 1 of enterohemorrhagic Escherichia coli by gallocatechin gallate and epigallocatechin gallate. Food Control 42: 263–269.
32. Morgan, J.L., McNamara, J.T., and Zimmer, J. (2014) Mechanism of activation of bacterial cellulose synthase by cyclic di-GMP. Nat Struct Mol Biol 21: 489–496.
33. Nakayama, M., Shimatania, K., Ozawaa, T., Shigemunea, N., Tsugukunia, T., Tomiyamaa, D., et al. (2013) A study of the antibacterial mechanism of catechins: isolation and identification of Escherichia coli cell surface proteins that interact with epigallocatechin gallate. Food Control 33: 433–439.
34. Noormandi, A., and Dabaghzadeh, F. (2015) Effects of green tea on Escherichia coli as a uropathogen. J Tradit Complement Med 5: 15–20.
35. Papenfort, K., Pfeiffer, V., Mika, F., Lucchini, S., Hinton, J.C., and Vogel, J. (2006) SigmaE-dependent small RNAs of Salmonella respond to membrane stress by accelerating global omp mRNA decay. Mol Microbiol 62: 1674–1688.
36. Parsek, M.R., and Greenberg, E.P. (2005) Sociomicrobiology: the connections between quorum sensing and biofilms. Trends Microbiol 13: 27–33.
37. Pesavento, C., Becker, G., Sommerfeldt, N., Possling, A., Tschowri, N., Mehlis, A., and Hengge, R. (2008) Inverse regulatory coordination of motility and curli-mediated adhesion in Escherichia coli. Genes Dev 22: 2434–2446.
38. Povolotsky, T.L., and Hengge, R. (2015) Genome-based comparison of c-di-GMP signaling in pathogenic and commensal Escherichia coli strains. J Bacteriol, 198: 111–126.
39. Richter, A.M., Povolotsky, T.L., Wieler, L.H., and Hengge, R. (2014) Cyclic-di-GMP signalling and biofilm-related properties of the Shiga toxin-producing 2011 German outbreak Escherichia coli O104:H4. EMBO Mol Med 6: 1622–1637.
40. Romero, D., Sanabria-Valentin, E., Vlamakis, H., and Kolter, R. (2013) Biofilm inhibitors that target amyloid proteins. Chem Biol 20: 102–110.
41. Römling, U., Rohde, M., Olsen, A., Normark, S., and Reinkoster, J. (2000) AgfD, the checkpoint of multicellular and aggregative behaviour in Salmonella typhimurium regulates at least two independent pathways. Mol Microbiol 36: 10–23.
42. Sambanthamoorthy, K., Sloup, R.E., Parashar, V., Smith, J.M., Kim, E.E., Semmelhack, M.F., et al. (2012) Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation. Antimicrob Agents Chemother 56: 5202–5211.
43. Serafini, M., Del Rio, D., Yao, D.N., Bettuzzi, S., and Peluso, I. (2011) Health benefits of tea. In Herbal Medicine: Biomolecular and Clinical Aspects. I.F.F. Benzie and Wachtel-Galor, S. (eds.). Boca Raton (FL): CRC press, pp. 239–261.
44. Serra, D.O., and Hengge, R. (2014) Stress responses go three dimensional – the spatial order of physiological differentiation in bacterial macrocolony biofilms. Env Microbiol 16: 1455–1471.
45. Serra, D.O., Richter, A.M., and Hengge, R. (2013a) Cellulose as an architectural element in spatially structured Escherichia coli biofilms. J Bacteriol 195: 5540–5554.
46. Serra, D.O., Richter, A.M., Klauck, G., Mika, F., and Hengge, R. (2013b) Microanatomy at cellular resolution and spatial order of physiological differentiation in a bacterial biofilm. mBio 4: e00103–00113.
47. Steinmann, J., Buer, J., Pietschmann, T., and Steinmann, E. (2013) Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br J Pharmacol 168: 1059–1073.
48. Sudano Roccaro, A., Blanco, A.R., Giuliano, F., Rusciano, D., and Enea, V. (2004) Epigallocatechin-gallate enhances the activity of tetracycline in Staphylococci by inhibiting its efflux from bacterial cells. Antimicrob Agents Chemother 48: 1968–1973.
49. Thomason, M.K., Fontaine, F., De Lay, N., and Storz, G. (2012) A small RNA that regulates motility and biofilm formation in response to changes in nutrient availability in Escherichia coli. Mol Microbiol 84: 17–35.
50. Tükel, C., Nishimori, J.H., Wilson, R.P., Winter, M.G., Keestra, A.M., van Putten, J.P., and Baumler, A.J. (2010) Toll-like receptors 1 and 2 cooperatively mediate immune responses to curli, a common amyloid from enterobacterial biofilms. Cell Microbiol 12: 1495–1505.
51. Ullmann, U., Haller, J., Decourt, J.D., Girault, J., Spitzer, V., and Weber, P. (2004) Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers. Int J Vitam Nutr Res 74: 269–278.
52. Urban, J.H., and Vogel, J. (2007) Translational control and target recognition by Escherichia coli small RNAs in vivo. Nucleic Acids Res 35: 1018–1037.
53. Zhou, Y., Smith, D.R., Hufnagel, D.A., and Chapman, M.R. (2013) Experimental manipulation of the microbial functional amyloid called curli. Methods Mol Biol 966: 53–75.
54. Zogaj, X., Nimtz, M., Rohde, M., Bokranz, W., and Römling, U. (2001) The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix. Mol Microbiol 39: 1452–1463.